An economic analysis of intravenous carboplatin plus dose-dense weekly paclitaxel versus intravenous carboplatin plus every three-weeks paclitaxel in the upfront treatment of ovarian cancer

✍ Scribed by H. Dalton; X. Yu; L. Hu; B. Monk; I. Benjamin; J. Chan

• Book ID: 113962758
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 86 KB
• Volume: 120
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2010.12.035